Le Lézard
Classified in: Health
Subjects: POL, AVO

Time is Running Out for Congress To Reverse Clinical Labor Cuts


USPA calls for action by the end of year to avoid cuts

WASHINGTON, Dec. 12, 2022 /PRNewswire/ -- This week, the United Specialists for Patient Access (USPA) is urging Congress to stop the finalized clinical labor and EM cuts included in the 2023 Medicare Physician Fee Schedule from going into effect December 31. Barring congressional action, the cuts will begin to undermine the quality care for patients starting in January.

USPA has warned that these clinical labor cuts will disproportionately impact specialists who care for Medicare beneficiaries in community-based, office settings. In addition, the cuts will continue to accelerate the health system consolidation trend, exacerbate health inequities, and threaten the pandemic resilience of our healthcare system.

Dozens of healthcare organizations have joined together to call for immediate congressional action. Learn more about the issue here.

"The clock is ticking, and Congress needs to act immediately in order to prevent these cuts before it's too late," said Dr. Mark Garcia, USPA board member and CMO for American Vascular Associates. "There is bipartisan support to stop this MPFS  from going into effect and causing an earthquake in our healthcare system. The House and Senate can protect patients by stopping these painful cuts before January 1."

About the United Specialists for Patient Access (USPA)

The mission of United Specialists for Patient Access is to unify and strengthen the voice of office-based specialists, enabling professionals and patient advocates to work collaboratively with Congress and the Administration and achieve near-term relief and long-term payment stability in the Physician Fee Schedule. For more information, please click here: www.uspaccess.org.

SOURCE United Specialists for Patient Access (USPA)


These press releases may also interest you

at 12:36
Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of plasma-derived therapeutic products used in treating rare and serious diseases, announced today that...

at 12:28
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDItm (mavorixafor), recently approved by the U.S....

at 12:20
Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its latest pharmacy and ambulatory infusion center (AIC) in Ridgeland, Mississippi. Soleo Health Jackson offers a broad range of specialty...

at 12:08
Prices have gone up?and stayed up?since the pandemic, but Eyemart Express has bucked this consumer pricing trend by keeping its prescription eyewear affordable. Since its founding in 1990, the national optical retailer has remained committed to...

at 12:05
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic...

at 12:05
Pharmaceutical Strategies Group ("PSG"), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability. The...



News published on and distributed by: